This framework describes the building blocks being laid down by the European Centre for Disease Prevention and Control (ECDC) to support and empower European Union (EU)/European Economic Area (EEA) countries and the European Commission in achieving microbial safety for substances of human origin (SoHO).
On 5 and 6 September, ECDC hosted the first joint SoHO-Net Tissues and Cells (TC) and Medically Assisted Reproduction (MAR) group meeting in Stockholm, Sweden.
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
Repository of resources produced by national public health institutes, national ministries of health, or recognised and respected learned societies or academies.
In order to assist Member States with the implementation of the new requirements, the EU Commission asked ECDC to construct a map indicating HTLV-1 high-prevalence areas in the world.
This report summarises the discussion and outcomes of an expert consultation on communicable diseases transmissible through substances of human origin (SoHO) which took place at the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden, on 20 and 21 September 2011.
Following a request from the European Commission in August 2010, ECDC assessed the epidemiological history of Human T-lymphotropic Virus (HTLV) across the world, possible risks of HTLV transmission through transplantation of human tissues and cells, and possible measures to prevent such transmission.